Confluence Investment Management LLC boosted its stake in shares of Becton Dickinson and Co. (NYSE:BDX) by 3.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 70,337 shares of the company’s stock after buying an additional 2,518 shares during the period. Confluence Investment Management LLC’s holdings in Becton Dickinson and were worth $12,642,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in BDX. Catawba Capital Management VA boosted its stake in shares of Becton Dickinson and by 0.4% in the third quarter. Catawba Capital Management VA now owns 44,282 shares of the company’s stock valued at $7,959,000 after buying an additional 190 shares during the last quarter. Hartford Investment Management Co. boosted its stake in shares of Becton Dickinson and by 0.9% in the second quarter. Hartford Investment Management Co. now owns 60,471 shares of the company’s stock valued at $10,255,000 after buying an additional 563 shares during the last quarter. Cullen Frost Bankers Inc. boosted its stake in shares of Becton Dickinson and by 0.4% in the second quarter. Cullen Frost Bankers Inc. now owns 84,551 shares of the company’s stock valued at $14,339,000 after buying an additional 356 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Becton Dickinson and by 13.9% in the second quarter. Bank of New York Mellon Corp now owns 2,395,262 shares of the company’s stock valued at $406,211,000 after buying an additional 291,429 shares during the last quarter. Finally, Bourgeon Capital Management LLC boosted its stake in shares of Becton Dickinson and by 1.3% in the second quarter. Bourgeon Capital Management LLC now owns 29,265 shares of the company’s stock valued at $4,963,000 after buying an additional 370 shares during the last quarter. 81.35% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Shares of Becton Dickinson and Co. (NYSE:BDX) traded up 1.67% during mid-day trading on Tuesday, reaching $173.16. The company’s stock had a trading volume of 595,327 shares. Becton Dickinson and Co. has a 52-week low of $129.50 and a 52-week high of $181.76. The firm has a 50 day moving average price of $171.40 and a 200 day moving average price of $172.45. The firm has a market cap of $36.77 billion, a price-to-earnings ratio of 38.57 and a beta of 1.04.

Becton Dickinson and (NYSE:BDX) last issued its earnings results on Thursday, November 3rd. The company reported $2.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.09 by $0.03. Becton Dickinson and had a return on equity of 24.45% and a net margin of 7.82%. The company earned $3.23 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the previous year, the company posted $1.94 EPS. The firm’s revenue for the quarter was up 5.6% compared to the same quarter last year. On average, equities analysts predict that Becton Dickinson and Co. will post $9.52 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 30th. Investors of record on Friday, December 9th will be issued a dividend of $0.73 per share. This is a boost from Becton Dickinson and’s previous quarterly dividend of $0.66. This represents a $2.92 annualized dividend and a yield of 1.71%. The ex-dividend date is Wednesday, December 7th. Becton Dickinson and’s dividend payout ratio (DPR) is presently 58.54%.

COPYRIGHT VIOLATION WARNING: This piece was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another site, it was stolen and republished in violation of US & international copyright law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2016/11/29/confluence-investment-management-llc-purchases-2518-shares-of-becton-dickinson-and-co-bdx.html.

A number of equities research analysts have issued reports on BDX shares. Citigroup Inc. cut Becton Dickinson and from a “neutral” rating to a “sell” rating and decreased their target price for the stock from $167.00 to $165.00 in a research report on Friday, September 23rd. Argus reaffirmed a “buy” rating and set a $185.00 target price on shares of Becton Dickinson and in a research report on Friday, October 21st. Zacks Investment Research cut Becton Dickinson and from a “buy” rating to a “hold” rating in a research report on Wednesday, November 16th. Leerink Swann reaffirmed a “market perform” rating and set a $185.00 target price (up previously from $180.00) on shares of Becton Dickinson and in a research report on Monday, November 21st. Finally, Deutsche Bank AG reaffirmed a “buy” rating and set a $189.00 target price (down previously from $197.00) on shares of Becton Dickinson and in a research report on Friday, November 4th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. Becton Dickinson and currently has a consensus rating of “Buy” and a consensus price target of $175.65.

In related news, insider Stephen Sichak sold 10,352 shares of Becton Dickinson and stock in a transaction that occurred on Friday, November 4th. The stock was sold at an average price of $176.10, for a total transaction of $1,822,987.20. Following the completion of the sale, the insider now directly owns 26,892 shares of the company’s stock, valued at approximately $4,735,681.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Linda M. Tharby sold 11,704 shares of Becton Dickinson and stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total value of $2,074,768.08. Following the sale, the insider now directly owns 22,146 shares of the company’s stock, valued at $3,925,821.42. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

About Becton Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Receive News & Stock Ratings for Becton Dickinson and Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Co. and related stocks with our FREE daily email newsletter.